MATURATION OF HEPATOSOMAL MONOOXYGENATION AND GLUCURONIDATION ACTIVITIES IN PRE-TERM AND FULL-TERM INFANTS AS STUDIED USING THE [N-15]METHACETIN URINE TEST
P. Krumbiegel et al., MATURATION OF HEPATOSOMAL MONOOXYGENATION AND GLUCURONIDATION ACTIVITIES IN PRE-TERM AND FULL-TERM INFANTS AS STUDIED USING THE [N-15]METHACETIN URINE TEST, Acta paediatrica, 86(11), 1997, pp. 1236-1240
The non-distressing [N-15]methacetin liver function test was modified
and applied to newborn healthy infants in order to measure both the to
tal [N-15]methacetin metabolites excreted in the urine (total eliminat
ion capacity) and the proportion of glucuronated metabolite. By studyi
ng pre-and full-term normotrophic neonates 3-168 days old, the age-dep
endent maturation of the two developing liver function processes can b
e compared on the basis of either postnatal or postmenstrual age. When
solely considering postnatal age, no significant differences between
the pre-and full-term infants were observed in the development of the
total elimination capacity. However, when postmenstrual age was consid
ered, it became apparent that this development starts earlier in pre-t
erm infants and continues at the same rate as their full-term counterp
arts, up to the postmenstrual age of approximately 280 days. This incr
ease subsequently diminishes in the pre-terms. In the same study group
, the proportion of glucuronidation, another indicator of the hepatic
detoxification system, appears to develop at a lower rate in pre-term
than in full-term infants. When postmenstrual age is taken into consid
eration, glucuronidation development is also observed to begin earlier
in pre-term infants and the slower maturation is more pronounced. Alt
hough these results are not generally applicable, they contribute to a
better interpretation of the [N-15]methacetin liver function test-for
instance when estimating effects due to environmental exposure or acc
urately calculating age-related drug dosage for neonates.